Colinz Laboratories Hits New 52-Week Low at Rs. 36.11

Colinz Laboratories has reached a new 52-week low, hitting Rs. 36.11 today, November 13, 2025. This marks a significant decline for the microcap pharmaceutical and biotechnology company, which has seen a year-to-date performance drop of 32.98%. Despite today's downturn, the stock has outperformed its sector by 3.98% and has shown a consecutive gain over the past three days, rising by 4.8% during this period.
The stock opened with a notable loss of 9.73% and experienced high volatility, with an intraday fluctuation of 8.7%. It touched a day's high of Rs. 43, reflecting a 7.5% increase from its opening price. In terms of moving averages, Colinz Laboratories is currently above its 5-day and 20-day averages but below its 50-day, 100-day, and 200-day averages.

The broader market context shows the Sensex trading slightly negative after a flat opening, while small-cap stocks are leading with a gain of 0.29%. Colinz Laboratories continues to face challenges, including weak long-term fundamentals and a low return on equity, which contribute to its current market position.